Natural history of trachomatous scarring in The Gambia: Results of a 12-year longitudinal follow-up

Ophthalmology

Volumn 108, Issue 12, 2001, Pages 2219-2224

  Bowman, Richard J C ^a,d   Jatta, Buba ^b   Cham, Bakary ^b   Bailey, Robin L ^c   Faal, Hannah ^b   Myatt, Mark ^a   Foster, Allen ^c   Johnson, Gordon J ^a  

^a International Centre for Eye Health   (United Kingdom)

^b National Eye Care Programme   (Gambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLINDNESS; CHILD; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA DISEASE; CONTROLLED STUDY; CORNEA OPACITY; DISEASE ASSOCIATION; DISEASE COURSE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TRACHOMA; TRICHIASIS; VISUAL IMPAIRMENT;

EID: 0035178845     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00645-5     Document Type: Article

References (16)

1. A simple system for the assessment of trachoma and its complications
2. Incidence estimates of late stages of trachoma among women in a hyperendemic area of central Tanzania
3. Trachoma in Punjabi Indians in British Columbia. A prevalence study with comparisons to India
4. Trachoma in The Gambia
5. National survey of blindness and low vision in The Gambia: Results
6. Limbal disease in trachoma and other ocular chlamydial infections: Risk factors for corneal vascularisation
7. A controlled trial of surgery for trachomatous trichiasis of the upper lid
8. Importance of reinfection in the pathogenesis of trachoma
9. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens
10. Anatomical factors influencing development of trichiasis and entropion in trachoma
11. The anatomy of the lower eyelid and its relations to the cause and cure of entropion
12. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid